🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Business Archived • October 20, 2026 • 2 views
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"Camping the Easyway"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Output is a realization of Input."
"We build AI or anything ICST"